ATLANTA, March 1, 2011 /PRNewswire/ -- A new patent brokerage services and advisory firm, Adapt IP Ventures, LLC (www.adaptipventures.com), announces its launch. The company specializes in developing customized patent brokerage and advisory solutions for promoting and selling a broad range of intellectual property related to medical devices, biotech/pharma, technology, software, energy and financial services.
Dr. Philip Kennedy, CEO of Neural Signals, Inc., recently retained Adapt IP Ventures. Dr. Kennedy believes "Adapt IP Ventures offers a unique and comprehensive approach to marketing a complex patent portfolio to leading medical device companies. I feel like I have a well aligned partnership with Adapt IP Ventures to ensure an optimal result."
Adapt IP Ventures is focused on client satisfaction and recognizes the importance of forming a close working relationship with clients. Additionally, the firm takes constant steps to fully understand and address the motivations and needs of the diverse set of strategic and financial buyers. Adapt IP Ventures commits to increasing the probability of completing a transaction by delivering innovative solutions, utilizing industry experts and accessing state-of-the-art research tools.
For more information, visit www.adaptipventures.com.
SOURCE Adapt IP Ventures, LLC